Testosterone replacement and prostate cancer
This article is intended as a review of the available clinical data outlining the risks and benefits of testosterone (androgen) replacement therapy, specifically addressing the issue of the relationship between exogenous androgen administration and prostate cancer risk. There is controversy over whe...
Main Authors: | Ranjith Ramasamy, Erik S Fisher, Peter N Schlegel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Urology |
Subjects: | |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2012;volume=28;issue=2;spage=123;epage=128;aulast=Ramasamy |
Similar Items
-
Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
by: Jin Wook Kim
Published: (2020-05-01) -
Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
by: Michael A. Bell, et al.
Published: (2018-05-01) -
Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?
by: Octavio A. Castillo, et al.
Published: (2015-04-01) -
A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
by: Andrew Morton, et al.
Published: (2021-01-01) -
Risks of testosterone replacement therapy in men
by: E Charles Osterberg, et al.
Published: (2014-01-01)